Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Smart Money Maintains Confidence In Plexus Corp. (PLXS)

Page 1 of 2

It’s a little-known fact that stock performance is not evenly distributed (i.e. you don’t have a 50/50 chance of picking a market-beating stock). In fact, despite the S&P 500 gaining about 5.2% between November 1, 2014 and October 30, 2015, less than 49% of the stocks in the index beat the market during that time. In contrast, the 30 stocks from the index which were the most popular among the investors that we track returned 9.5% during that time and 63% of them beat the market. This shows that while hedge funds get a lot of flak from the mainstream media for their performance, it can be rewarding to follow their moves using the right sets of data. Even then, there is never a fool proof strategy to generating returns, as even the collective wisdom of top hedge funds gets it wrong some times, as in the case of some of their top picks from the index like Micron and Anadarko. The data though, shows that following the collective wisdom of select hedge funds can be a very wise move overall.

Plexus Corp. (NASDAQ:PLXS) shares haven’t seen a lot of action during the third quarter. Overall, hedge fund sentiment was unchanged. The stock was in 15 hedge funds’ portfolios at the end of September. At the end of this article we will also compare Plexus Corp. to other stocks including Super Micro Computer, Inc. (NASDAQ:SMCI), Franklin Electric Co. (NASDAQ:FELE), and TransAlta Corporation (USA) (NYSE:TAC) to get a better sense of its popularity.

Follow Plexus Corp (NASDAQ:PLXS)
Trade (NASDAQ:PLXS) Now!

To most investors, hedge funds are perceived as worthless, old investment vehicles of years past. While there are over 8,000 funds in operation at the moment, our experts choose to focus on the top tier of this group, approximately 700 funds. Most estimates calculate that this group of people control most of the hedge fund industry’s total asset base, and by observing their unrivaled stock picks, Insider Monkey has unsheathed various investment strategies that have historically outstripped the S&P 500 index. Insider Monkey’s small-cap hedge fund strategy outrun the S&P 500 index by 12 percentage points annually for a decade in their back tests.

With all of this in mind, we’re going to take a look at the latest action encompassing Plexus Corp. (NASDAQ:PLXS).

How have hedgies been trading Plexus Corp. (NASDAQ:PLXS)?

At Q3’s end, a total of 15 of the hedge funds tracked by Insider Monkey were bullish on this stock, unchanged from the previous quarter. With the smart money’s positions undergoing their usual ebb and flow, there exists a select group of key hedge fund managers who were boosting their stakes meaningfully (or had already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Fisher Asset Management, managed by Ken Fisher, holds the largest position in Plexus Corp. (NASDAQ:PLXS). Fisher Asset Management has a $30.9 million position in the stock, comprising 0.1% of its 13F portfolio. The second-most bullish fund manager is Anand Parekh of Alyeska Investment Group, with a $26.8 million position; the fund has 0.3% of its 13F portfolio invested in the stock. Some other professional money managers that are bullish include Chuck Royce’s Royce & Associates, Clint Carlson’s Carlson Capital, and Joel Greenblatt’s Gotham Asset Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!